Clinical Efficacy of Continuous Renal Replacement Therapy in Severe Burn Sepsis

Saiqiong ZHANG; Wuquan LI; Qingjiang CHEN

doi:10.12259/j.issn.2095-610X.S20231114

Volume 44 Issue 11

Nov. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2023 > 44(11): 94-99

Saiqiong ZHANG, Wuquan LI, Qingjiang CHEN. Clinical Efficacy of Continuous Renal Replacement Therapy in Severe Burn Sepsis[J]. Journal of Kunming Medical University, 2023, 44(11): 94-99. doi: 10.12259/j.issn.2095-610X.S20231114

Citation:

Saiqiong ZHANG, Wuquan LI, Qingjiang CHEN. Clinical Efficacy of Continuous Renal Replacement Therapy in Severe Burn Sepsis[J]. Journal of Kunming Medical University, 2023, 44(11): 94-99. doi: 10.12259/j.issn.2095-610X.S20231114

Citation:

PDF( 622 KB)

Clinical Efficacy of Continuous Renal Replacement Therapy in Severe Burn Sepsis

doi: 10.12259/j.issn.2095-610X.S20231114

Burn Research Institute，The 2nd Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650101，China

Received Date: 2022-09-01
Publish Date: 2023-11-25

Abstract

Abstract

Objective To investigate the clinical efficacy of continuous renal replacement therapy（CRRT） in patients with severe burn sepsis. Methods Forty patients with sepsis caused by severe burns who met the inclusion criteria and were admitted to the Department of Burns of the Second Affiliated Hospital of Kunming Medical University from January 2020 to January 2023 were retrospectively analyzed. According to the treatment, patients were divided into control group and treatment group, with 20 patients in each group. The control group was given conventional symptomatic and supportive treatment, and the treatment group was given continuous renal replacement therapy on the basis of conventional treatment. The venous blood of the control group and the treatment group was taken before treatment and 24, 48, 72 hours after treatment. White blood cells（WBC）, calcitonin（PCT）, serum creatinine（Scr）, blood urea nitrogen（BUN） level. In addition, the length of hospital stay and the total cost of hospitalization were compared between the two groups. Results Before treatment, the levels of C-reactive protein（CRP）, interleukin-6（IL-6）, white blood cell（WBC）, procalcitonin（PCT）, serum creatinine（Scr） and blood urea nitrogen（BUN） in the two groups were compared, the P value was above 0.05, and the difference was not significant in the statistical data. 72 hours after treatment group C reactive protein（CRP） and interleukin 6（IL - 6）, white blood cell（WBC）, calcitonin（PCT）, serum creatinine（Scr）, blood urea nitrogen（BUN） level, the results show that numerical value was lower than the control group, experimental group and the difference between the P value is less than 0.05, has significant statistical significance. In addition, the length of hospital stay and total hospital costs were also statistically lower in the CRRT group than in the usual care group. Conclusion In severe burn patients with sepsis, continuous renal replacement therapy has a significant effect, which can effectively remove inflammatory mediators, prevent and treat uncontrolled inflammatory response, and effectively relieve the symptoms caused by systemic infections such as burn wound sepsis. It has a good application prospect in the prevention and treatment of stress injury and organ injury caused by sepsis in clinical practice. At the same time, it can also bring certain economic and social benefits.
- Continuous renal replacement therapy,
- Severe burns,
- Sepsis,
- Systemic inflammatory response syndrome

FullText(HTML)

References(23)

References

[1]	Krzyzaniak K, Krion R, Szymczyk A, et al. Exploring neuroprotective agents for sepsis-associated encephalopathy: A comprehensive review [J]. International Journal of Molecular Sciences, 2023, 24（13）: 10789.
[2]	Wang Z, Liu L, Liu L. Vitamin C as a treatment for organ failure in sepsis [J]. European Journal of Medical Research, 2023, 28（1）: 222.
[3]	Boldeanu L,Boldeanu M V,Bogdan M,et al. Immunological approaches and therapy in burns (Review)[J]. Experimental and Therapeutic Medicine,2020,20(3):2361-2367.
[4]	Jeschke M G,Vanbaar M E,Choudhry M A,et al. Burn injury[J]. Nature Reviews Disease Primers,2020,6(1):11. doi: 10.1038/s41572-020-0145-5
[5]	Tandukar S,Palevsky PM. Continuous renal replacement therapy: who,hen,why,and how[J]. Chest,2019,155(3):626-638. doi: 10.1016/j.chest.2018.09.004
[6]	王岩,张爱霞,王紫晖,等. 连续性肾脏替代治疗在多器官功能障碍综合征中的应用[J]. 河南医学研究,2021,30(23):4300-4302. doi: 10.3969/j.issn.1004-437X.2021.23.020
[7]	Papafilippou L,Claxton A,Dark P,et al. Nanotools for sepsis diagnosis and treatment[J]. Advanced Healthcare Materials,2021,10(1):e2001378. doi: 10.1002/adhm.202001378
[8]	Zhang X,Tang H,Huang Q,et al. Total hospital costs and length of stay of endovascular coiling versus neurosurgical clipping for unruptured intracranial aneurysms: systematic review and meta-analysis[J]. World Neurosurgery,2018,115:393-399. doi: 10.1016/j.wneu.2018.04.028
[9]	D'abbondanza J A,Shahrokhi S. Burn infection and burn sepsis[J]. Surg Infect (larchmt),2021,22(1):58-64. doi: 10.1089/sur.2020.102
[10]	Torres M J M,Peterson J M,Wolf S E. Detection of infection and sepsis in burns[J]. Surg Infect (larchmt),2021,22(1):20-27. doi: 10.1089/sur.2020.348
[11]	Srzić, I, Nesek Adam, V, Tunjić Pejak, D. Sepsis definition: what's new  in the treatment guidelines [J]. Acta Clinica Croatica, 2022, 61（suppl 1）: 67-72.
[12]	Shi X,Tan S,Tan S. Nlrp3 inflammasome in sepsis (review)[J]. Molecular Medicine Reports,2021,24(1):514. doi: 10.3892/mmr.2021.12153
[13]	Zeng G,Chen D,Zhou R,et al. Combination of c-reactive protein,procalcitonin,IL-6,IL-8,and IL-10 for early diagnosis of hyperinflammatory state and organ dysfunction in pediatric sepsis[J]. Journal of Clinical Laboratory Analysis,2022,36(7):e24505. doi: 10.1002/jcla.24505
[14]	Chen H,Li T,Yan S,et al. Pentraxin-3 is a strong biomarker of sepsis severity identification and predictor of 90-day mortality in intensive care units via sepsis 3.0 definitions[J]. diagnostics (Basel,Switzerland),2021,11(10):1906. doi: 10.3390/diagnostics11101906
[15]	Rehou S,Abdullahi A,Jeschke M G. Classic IL-6 signaling is associated with poor outcomes in burn patients[J]. Shock (augusta,ga),2023,59(2):155-160. doi: 10.1097/SHK.0000000000002051
[16]	Khaleel A,Al-barzinji R. Procalcitonin as new proinflammatory marker in burn patients[J]. Polytechnic Journal,2021,11(1):58-62. doi: 10.25156/ptj.v11n1y2021.pp58-62
[17]	Yu Y,Wu W,Dong Y,et al. C-reactive protein-to-albumin ratio predicts sepsis and prognosis in patients with severe burn injury[J]. Mediators of Inflammation,2021,2021:6621101.
[18]	Yang G,Tanl,Yao H,et al. Long-term effects of severe burns on the kidneys: research advances and potential therapeutic approaches[J]. Journal of Inflammation Research,2023,16:1905-1921. doi: 10.2147/JIR.S404983
[19]	Rehou S,Jeschke M G. Admission creatinine is associated with poor outcomes in burn patients[J]. Burns,2022,48(6):1355-1363. doi: 10.1016/j.burns.2021.07.022
[20]	Davenport A,Honore P M. Continuous renal replacement therapy under special conditions like sepsis,burn,cardiac failure,neurotrauma,and liver failure[J]. Seminars in Dialysis,2021,34(6):457-471. doi: 10.1111/sdi.13002
[21]	Macdougall H. Social work leadership in the provision of nonprofit hospital community benefits[J]. Health & Social work,2020,45(3):149-154.
[22]	Kyi-kokarieva V,Kriachkova L,Padalko L. Socio-economic substantiation of expediency of seasonal influenza vaccine prophylaxis among medical workers[J]. Medical Perspectives-medicni Perspektivi,2021,26(4):205-212. doi: 10.26641/2307-0404.2021.4.248235
[23]	黄巧红,朱同玉. 公立医院院长绩效考核中社会效益与经济效益系统耦合协调度分析[J]. 解放军医院管理杂志,2021,28(2):101-104. doi: 10.16770/J.cnki.1008-9985.2021.02.001

Relative Articles(20)

Relative Articles

[1]	Xing LIU, Weixian LI, Xiang ZHU, Mengxing LIU, Na LI, Jiawei XIA, Le ZHANG, Yan WU, Shenghao LI. Construction of a Nomogram Model of Tsutsugamushi Disease Complicated with Sepsis Based on Lasso Regression. Journal of Kunming Medical University, 2024, 45(9): 35-41. doi: 10.12259/j.issn.2095-610X.S20240906
[2]	Junjie NIU, Wenjuan JI, Zhuaizhuai YU. Correlation between Gut Microbiota，Serum ET，PCT Levels with the Severity and Prognosis of Sepsis. Journal of Kunming Medical University, 2024, 45(4): 140-145. doi: 10.12259/j.issn.2095-610X.S20240420
[3]	Congxin LI, Haidong YUE, Pengxi ZHU, Guangxian HUANG, Lingjie MU, Yanan PENG, Yijie WANG, Yang YANG. Correlation analysis between different vitamin D levels and immune inflammatory indicators in elderly patients with sepsis. Journal of Kunming Medical University, 2024, 46(): 1-9.
[4]	Ruoyu WANG, Wei CHEN, Xun XU, Wende CAO, Yulan MIAO. Epidemiological Investigation and Risk Factors Analysis of Systemic Inflammatory Response Syndrome in 329 Children with Burn. Journal of Kunming Medical University, 2024, 45(5): 123-129. doi: 10.12259/j.issn.2095-610X.S20240519
[5]	Linlin XUE, Binghan LI, Chunyun LIU, Weikun LI, Lixian CHANG, Huimin LI, Yanwei QI, Li LIU. Establishment and Evaluation of a Nomogram for Predicting Potential Death in Patients with Hepatitis C Cirrhosis and Sepsis in General Wards. Journal of Kunming Medical University, 2023, 44(6): 113-119. doi: 10.12259/j.issn.2095-610X.S20230630
[6]	Wenzhuo LI, Li YANG, Jing XIA. Efficacy of Xinmailong Injection on Septic Cardiomyopathy. Journal of Kunming Medical University, 2022, 43(12): 111-116. doi: 10.12259/j.issn.2095-610X.S20221221
[7]	Hong WANG, Dexing YANG, Qiang WANG, Weiyu ZHOU, Jiefu TANG, Zhenfang WANG, Kai FU, Shengzhe LIU, Rong LIU. Risk Factors Analysis and Prediction Model Establishment of Refeeding Syndrome in ICU Patients with Sepsis. Journal of Kunming Medical University, 2022, 43(11): 44-51. doi: 10.12259/j.issn.2095-610X.S20221102
[8]	Bin HUANG, Rui-hua ZHAO, Qi-hua FEI, Jian-wei LI, Yan ZHI, Wen-jun LIU, Xiao-qing LI. Effect of Ulinastatin Combined with Continuous Renal Replacement Therapy in Treatment of Severe Burn Patients and Its Influence on Inflammatory Factors and 28-day all-cause Mortality. Journal of Kunming Medical University, 2020, 41(11): 109-113. doi: 10.12259/j.issn.2095-610X.S20201102
[9]	Xu Jian , Wang Zi Yu , Chen Yao Xiang , Mou Bo , Jin Yan , Ma Lei . . Journal of Kunming Medical University, 2019, 40(04): 97-100.
[10]	Liu Ya Ming , Xu Mian , Yan Yue Xin , Zhou Feng Gao , Xu Cheng , Zhao Kun , Jiang Guo Yun , Wu Yu, Liu Rong . . Journal of Kunming Medical University, 2019, 40(06): 16-22.
[11]	Huang Zhao Dan , Zhou Xing Liang , Chen Yan He , Lu Chang Qing , Wang Qing Yun . . Journal of Kunming Medical University, 2018, 39(09): 65-68.
[12]	Teng Yan . Effect of Hemoperfusion on Inflammation Factors in Patients with Sepsis. Journal of Kunming Medical University,
[13]	Guo Cui . . Journal of Kunming Medical University,
[14]	Zhang Meng Si . . Journal of Kunming Medical University,
[15]	Wang Jin . . Journal of Kunming Medical University,
[16]	Xu Ying . . Journal of Kunming Medical University,
[17]	Miao Yu Lan . . Journal of Kunming Medical University,
[18]	Miao Yu Lan . . Journal of Kunming Medical University,
[19]	. Clinical Effect of Xuebijing Injection on Pro/Anti-inflammatory Balance in Sepsis Patients. Journal of Kunming Medical University,
[20]	Cheng Si Gen . . Journal of Kunming Medical University,